Alberto Flores
Internal Medicine · Fort Worth, TXNPI 1770528010
Payments from drug & device makers
Across 91 payments — averaging $16.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$300
- Lilly USA, LLC$189
- GSK$138
- Boehringer Ingelheim$116
- Novo Nordisk$102
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$92
- plus $573 from 16 others
What the payments were for
- Food & beverage$1,48598%
- Education$262%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $300 |
| Lilly USA, LLC | 12 | $189 |
| GSK | 9 | $138 |
| Boehringer Ingelheim | 8 | $116 |
| Novo Nordisk | 7 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $92 |
| Sanofi-aventis U.S. LLC | 5 | $91 |
| Novartis | 5 | $86 |
| Pfizer | 4 | $69 |
| Johnson & Johnson | 5 | $68 |
| Genentech USA, Inc. | 3 | $40 |
| Cumberland Pharmaceuticals, Inc. | 3 | $35 |
| Gilead | 2 | $32 |
| Bayer | 2 | $32 |
| Amgen | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Mannkind Corporation | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $13 |
| Abbott | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $11 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$120
How this compares
$1,511 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bydureon BciseExenatide Microspheres | 147 | $162,784 |
| MounjaroTirzepatide | 51 | $57,035 |
| JardianceEmpagliflozin | 30 | $53,321 |
| OzempicSemaglutide | 35 | $43,114 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 51 | $38,094 |
| JanuviaSitagliptin Phosphate | 15 | $26,207 |
| EliquisApixaban | 14 | $25,016 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $15,272 |
| Pro Comfort Alcohol PadsAlcohol Antiseptic Pads | 88 | $11,174 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 84 | $9,585 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $8,980 |
| Atorvastatin Calcium | 782 | $4,819 |
| Comfort Touch Pen NeedlePen Needle, Diabetic | 25 | $4,577 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 259 | $3,829 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 15 | $3,274 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $189 | $57,03551 claims |
| Boehringer IngelheimJardiance | $116 | $53,32130 claims |
| Novo NordiskOzempic | $102 | $43,11435 claims |
| GSKTrelegy Ellipta, Shingrix | $138 | $41,36866 claims |
| PfizerEliquis | $69 | $25,01614 claims |
| Sanofi-aventis U.S. LLCLantus | $91 | $1,70417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Fort Worth
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.